Variation of COMT Val158Met Polymorphism Between COM-ON Patients and METHADOSE Patients
Conditions: Opioid-related Disorders; Opiate Dependence; Opiate Addiction; Opiate AbuseIntervention: Genetic: COMT polymorphismSponsor: Assistance Publique - Hôpitaux de ParisRecruiting - verified June 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2012 Category: Research Source Type: clinical trials
Variation of COMT Val158Met Polymorphism Between COM-ON Patients and METHADOSE Patients
Conditions: Opioid-related Disorders; Opiate Dependence; Opiate Addiction; Opiate AbuseIntervention: Genetic: COMT polymorphismSponsor: Assistance Publique - Hôpitaux de ParisRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2012 Category: Research Source Type: clinical trials
Variation of COMT Val158Met Polymorphism Between COM-ON Patients and METHADOSE Patients
Conditions: Opioid-related Disorders; Opiate Dependence; Opiate Addiction; Opiate AbuseIntervention: Genetic: COMT polymorphismSponsor: Assistance Publique - Hôpitaux de ParisRecruiting - verified June 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2012 Category: Research Source Type: clinical trials
Variation of COMT Val158Met Polymorphism Between COM-ON Patients and METHADOSE Patients
Conditions: Opioid-related Disorders; Opiate Dependence; Opiate Addiction; Opiate AbuseIntervention: Genetic: COMT polymorphismSponsor: Assistance Publique - Hôpitaux de ParisRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2012 Category: Research Source Type: clinical trials